• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PARP-1 在高糖诱导的内皮损伤中的双向调节作用。

Bidirectional regulation role of PARP-1 in high glucose-induced endothelial injury.

机构信息

Department of Endocrinology, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.

Department of Emergency, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Exp Cell Res. 2022 Dec 15;421(2):113400. doi: 10.1016/j.yexcr.2022.113400. Epub 2022 Oct 23.

DOI:10.1016/j.yexcr.2022.113400
PMID:36283454
Abstract

Loss of poly (ADP-ribose) polymerase-1 (PARP-1) has been found to slow the progression of diabetes and diabetic angiopathy. In our study, we found bidirectional regulation of PARP-1 in high glucose induced endothelial injury, which promoting repair at the early stage of injury and inhibiting repair at the late stage of injury. To further investigate the mechanism of PARP-1 regulation, we first examined the expression of PARP-1 in aortic tissues and cultured cells at early, middle, and late stages of injury, PARP-1 expression was significantly greater than that of control group. Overexpression of PARP-1 in HUVECs significantly reduced the number of apoptotic cells 12 h after high glucose injury, while reducing the level of reactive oxygen species (ROS)/malondialdehyde (MDA)/inducible nitric oxide synthase (iNOS), increasing the level of endothelial nitric oxide synthase (eNOS); however, when the injury extended to 3 days, the number of apoptosis in HUVECs overexpressing PARP-1 was significantly higher than that in the injury group, and the level of ROS/MDA/iNOS was significantly higher, while the secretion of eNOS was significantly lower. Similarly, PARP-1 inhibitors aggravate early damage and inhibit late damage. We found that PARP-1 promoted the activation of P53 and P53R2 in endothelial cells after 12 h of injury, and PARP-1 promoted the activation of P53 and caspas3 in endothelial cells after 3 days of injury. Therefore, we suggest that PARP-1 plays a dual regulatory role in promoting repair or aggravating injury.

摘要

聚 ADP-核糖聚合酶 1(PARP-1)的缺失已被发现可减缓糖尿病和糖尿病血管病变的进展。在我们的研究中,我们发现高葡萄糖诱导的内皮损伤中存在 PARP-1 的双向调节,即在损伤的早期促进修复,而在损伤的晚期抑制修复。为了进一步研究 PARP-1 调节的机制,我们首先检查了损伤早期、中期和晚期主动脉组织和培养细胞中 PARP-1 的表达,PARP-1 的表达明显高于对照组。在 HUVECs 中过表达 PARP-1 可显著减少高葡萄糖损伤后 12 小时的凋亡细胞数量,同时降低活性氧(ROS)/丙二醛(MDA)/诱导型一氧化氮合酶(iNOS)水平,增加内皮型一氧化氮合酶(eNOS)水平;然而,当损伤持续 3 天时,过表达 PARP-1 的 HUVECs 中的凋亡数量明显高于损伤组,并且 ROS/MDA/iNOS 水平明显升高,而 eNOS 的分泌明显降低。同样,PARP-1 抑制剂加重早期损伤并抑制晚期损伤。我们发现,PARP-1 在损伤后 12 小时促进内皮细胞中 P53 和 P53R2 的激活,在损伤后 3 天促进内皮细胞中 P53 和 caspas3 的激活。因此,我们认为 PARP-1 在促进修复或加重损伤方面发挥双重调节作用。

相似文献

1
Bidirectional regulation role of PARP-1 in high glucose-induced endothelial injury.PARP-1 在高糖诱导的内皮损伤中的双向调节作用。
Exp Cell Res. 2022 Dec 15;421(2):113400. doi: 10.1016/j.yexcr.2022.113400. Epub 2022 Oct 23.
2
Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction.聚(ADP - 核糖)聚合酶1抑制作用可预防年龄依赖性内皮功能障碍。
Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1266-74. doi: 10.1111/1440-1681.12484.
3
Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.聚(ADP-核糖)聚合酶抑制通过促进血管生成增强缺血性和糖尿病性伤口愈合。
J Vasc Surg. 2017 Apr;65(4):1161-1169. doi: 10.1016/j.jvs.2016.03.407. Epub 2016 Jun 8.
4
Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.聚(ADP-核糖)聚合酶抑制剂激活神经干/祖细胞中的p53信号通路。
BMC Neurosci. 2017 Jan 17;18(1):14. doi: 10.1186/s12868-016-0333-0.
5
Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.聚(ADP - 核糖)聚合酶1抑制可保护心肌细胞免受糖尿病心肌病中的炎症和凋亡影响。
Oncotarget. 2016 Jun 14;7(24):35618-35631. doi: 10.18632/oncotarget.8343.
6
Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.聚(ADP-核糖)聚合酶抑制通过抑制线粒体自噬来保护心肌缺血/再灌注损伤。
J Cell Mol Med. 2019 Oct;23(10):6897-6906. doi: 10.1111/jcmm.14573. Epub 2019 Aug 5.
7
Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.聚(ADP-核糖)聚合酶1抑制可预防低切应力诱导的炎症。
Biochim Biophys Acta. 2013 Jan;1833(1):59-68. doi: 10.1016/j.bbamcr.2012.10.013. Epub 2012 Oct 22.
8
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
9
Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.聚(ADP - 核糖)聚合酶 -1的结构与功能:在氧化应激相关病症中的作用
Curr Vasc Pharmacol. 2005 Jul;3(3):209-14. doi: 10.2174/1570161054368625.
10
Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension.抑制聚(ADP-核糖)聚合酶-1(PARP-1)可改善肺动脉高压中的内皮功能。
Pulm Pharmacol Ther. 2023 Jun;80:102200. doi: 10.1016/j.pupt.2023.102200. Epub 2023 Feb 25.

引用本文的文献

1
PARP (Poly ADP-ribose Polymerase) Family in Health and Disease.健康与疾病中的PARP(聚ADP核糖聚合酶)家族
MedComm (2020). 2025 Sep 1;6(9):e70314. doi: 10.1002/mco2.70314. eCollection 2025 Sep.
2
The Role of p53 in Regulating Chronic Inflammation and PANoptosis in Diabetic Wounds.p53在调节糖尿病伤口慢性炎症和PANoptosis中的作用
Aging Dis. 2024 Feb 19;16(1):373-93. doi: 10.14336/AD.2024.0212.
3
PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages.慢性炎症中的聚(ADP-核糖)聚合酶与ADP-核糖基化:聚焦巨噬细胞
Pathogens. 2023 Jul 23;12(7):964. doi: 10.3390/pathogens12070964.